Larixol
Larixol is a multi-target small molecule that inhibits fMLP-induced neutrophil activation by blocking key signaling pathways (Src, ERK, p38, AKT) and disrupting Gi protein βγ subunit interactions. It suppresses superoxide generation, cathepsin G release, and chemotaxis (IC50 ~2-3 μM), and its derivatives also inhibit FSGS-linked TRPC6 mutants, supporting research into inflammation and kidney disease.
Product Specifications
CAS Number
1438-66-0
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
C[C@]12[C@@] ([C@@H] (O) CC (=C) [C@@H]1CC[C@] (C=C) (C) O) (C (C) (C) CCC2) [H]
Molecular Formula
C20H34O2
Molecular Weight
306.48
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1047161-01 0.02 mg (E-Coli)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details MBS1047161-02 0.02 mg (Yeast)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details MBS1047161-03 0.1 mg (E-Coli)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details MBS1047161-04 0.1 mg (Yeast)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details MBS1047161-05 0.02 mg (Baculovirus)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details MBS1047161-06 0.02 mg (Mammalian-Cell)
Recombinant Anaerocellum thermophilum Xylose isomerase (xylA)
Sign In for Pricing
View Details